- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr J. Mario Molina Calls for Controlling Growing Medicaid Costs
Specialty drug costs represent a huge concern for Medicaid, which already represents the second largest budget in a state, according to J. Mario Molina, MD, president and chief executive officer of Molina Healthcare.
Specialty drug costs represent a huge concern for Medicaid, which already represents the second largest budget in a state, J. Mario Molina, MD, president and chief executive officer of Molina Healthcare, said in October at the National Conferences on Medicare and Medicaid, and Dual Eligibles Summit held by America’s Health Insurance Plans.
If Medicaid costs are not kept under control, states run the risk of the program’s growing budget cutting into other needed services, he explained.
“The funny thing is the government is willing to set pricing, especially on Medicare, for hospital services and physician services, but they’ve been unwilling to tackle pharmaceuticals,” Dr Molina said.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
